Purpose: To investigate if dynamic contrast-enhanced MRI in lungs could add new information to pulmonary hypertension in a newborn piglet model.
Materials and Methods:Six newborn piglets were subjected to instillation of meconium following treatment with sildenafil. Before and after both of these events, dynamic contrast-enhanced MRI was performed to determine pulmonary blood flow (PBF) using a model-free deconvolution of the dynamic signal-time curve, together with invasive measurements of mean airway pressure (PAW), cardiac output (CO), and oxygenation index (OI).Results: Meconium instillation caused a significant increase in PAW (P Ͻ 0.05) accompanied by a marked increase in OI, the average PBF in the four lung regions (apical-anterior, apical-posterior, distal-anterior, and distal-posterior) decreased significantly by 33% (P Ͻ 0.001), but it did not significantly affect CO. On the other hand, infusion of sildenafil caused a significant increase in CO (P Ͻ 0.01), and administration resulted mainly in an increased PBF in the distal parts of the lungs.
Conclusion:By using dynamic contrast-enhanced MRI, we demonstrated a marked decrease in PBF following instillation of meconium, which was not followed by an equivalent decrease in CO, suggesting that measurements of CO inadequately reflect the intrapulmonary changes in the blood circulation. PERSISTENT PULMONARY hypertension of the newborn remains a life-threatening condition characterized by marked pulmonary hypertension and altered vasoreactivity, eventually leading to right-to-left shunting of blood across the patent ductus arteriosus and foramen ovale. The high pulmonary vascular resistance (PVR) causes reduced flow and thereby decreased O 2 uptake. At the point at which PVR is higher than the systematic vascular resistance, right-to-left shunting occurs, resulting in severe hypoxemia. Current management of persistent pulmonary hypertension includes therapies that are targeted at lowering PVR, i.e., nitric oxide (NO) and agents like sildenafil. Sildenafil inhibits the breakdown of cGMP by phosphodiesterase-5, which leads to the relaxation of smooth muscle cells, mainly in the arteries of the lungs. In this study, we used meconium aspiration syndrome (MAS) as a model of pulmonary hypertension; MAS is a well-established model that can develop pulmonary hypertension within 120 minutes (1). In clinical settings, MAS is often accompanied by pulmonary hypertension and an increased oxygenation index (OI) with hypoxemia and signs of low oxygenation such as lactic acidosis, which has further been documented in experimental studies using pulmonary artery wedge catheters (2). Thus, the monitoring and evaluation of treatment is conventionally based on measurements of these parameters. However, changes in cardiac output (CO), OI, and PVR do not necessarily reflect changes in the regional capillary blood flow.The pulmonary circulation of blood should therefore be revealed by measurements of regional pulmonary blood flow (PBF), which can be estimated from analysis of dynami...